These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 28859329

  • 1. Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase.
    Knieper AM, Klotsche J, Lainka E, Berger T, Dressler F, Jansson AF, Rietschel C, Oommen PT, Berendes R, Niehues T, Neudorf U, Foell D, Wittkowski H, Kallinich T.
    Rheumatology (Oxford); 2017 Sep 01; 56(9):1597-1606. PubMed ID: 28859329
    [Abstract] [Full Text] [Related]

  • 2. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
    Kallinich T, Wittkowski H, Keitzer R, Roth J, Foell D.
    Ann Rheum Dis; 2010 Apr 01; 69(4):677-82. PubMed ID: 19762364
    [Abstract] [Full Text] [Related]

  • 3. Colchicine treatment in children with familial Mediterranean fever.
    Ozkaya N, Yalçinkaya F.
    Clin Rheumatol; 2003 Oct 01; 22(4-5):314-7. PubMed ID: 14579163
    [Abstract] [Full Text] [Related]

  • 4. Colchicine is a safe drug in children with familial Mediterranean fever.
    Padeh S, Gerstein M, Berkun Y.
    J Pediatr; 2012 Dec 01; 161(6):1142-6. PubMed ID: 22738946
    [Abstract] [Full Text] [Related]

  • 5. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
    Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F, Bassoy Y, Yilmaz E.
    Clin Exp Rheumatol; 2003 Dec 01; 21(4):509-14. PubMed ID: 12942707
    [Abstract] [Full Text] [Related]

  • 6. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct 01; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 7. The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.
    Yoldaş TÇ, Çakar N, Başaran Ö, Acar B, Uncu N, Çaycı FŞ.
    Clin Rheumatol; 2016 Jun 01; 35(6):1603-7. PubMed ID: 26384820
    [Abstract] [Full Text] [Related]

  • 8. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.
    Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C, Stojanov S, Timmann C, Keitzer R, Ozdogan H, Ozen S.
    Pediatrics; 2007 Feb 01; 119(2):e474-83. PubMed ID: 17242135
    [Abstract] [Full Text] [Related]

  • 9. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
    Corsia A, Georgin-Lavialle S, Hentgen V, Hachulla E, Grateau G, Faye A, Quartier P, Rossi-Semerano L, Koné-Paut I.
    Orphanet J Rare Dis; 2017 Mar 16; 12(1):54. PubMed ID: 28302131
    [Abstract] [Full Text] [Related]

  • 10. Evidence-based recommendations for the practical management of Familial Mediterranean Fever.
    Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, Amselem S, Gershoni-Baruch R, Touitou I, Ben-Chetrit E.
    Semin Arthritis Rheum; 2013 Dec 16; 43(3):387-91. PubMed ID: 23742958
    [Abstract] [Full Text] [Related]

  • 11. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever.
    Berkun Y, Padeh S, Reichman B, Zaks N, Rabinovich E, Lidar M, Shainberg B, Livneh A.
    Semin Arthritis Rheum; 2007 Dec 16; 37(3):182-8. PubMed ID: 17512038
    [Abstract] [Full Text] [Related]

  • 12. Colchicine-induced leukopenia in a patient with familial Mediterranean fever: the cause and a possible approach.
    Ben-Chetrit E, Navon P.
    Clin Exp Rheumatol; 2003 Dec 16; 21(4 Suppl 30):S38-40. PubMed ID: 14727458
    [Abstract] [Full Text] [Related]

  • 13. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
    Sönmez HE, Batu ED, Bilginer Y, Özen S.
    Clin Rheumatol; 2017 Feb 16; 36(2):421-425. PubMed ID: 27679472
    [Abstract] [Full Text] [Related]

  • 14. Once-daily use of colchicine in children with familial Mediterranean fever.
    Koşan C, Ozkan B.
    Clin Pediatr (Phila); 2004 Sep 16; 43(7):605-8. PubMed ID: 15378145
    [Abstract] [Full Text] [Related]

  • 15. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients.
    Ozen F, Silan C, Uludag A, Candan F, Silan F, Ozdemir S, Atik S, Ozdemir O.
    Ren Fail; 2011 Sep 16; 33(9):899-903. PubMed ID: 21851199
    [Abstract] [Full Text] [Related]

  • 16. Semen analysis in adolescents with familial Mediterranean fever.
    Kaya Aksoy G, Koyun M, Usta MF, Çomak E, Akman S.
    J Pediatr Urol; 2019 Aug 16; 15(4):342.e1-342.e7. PubMed ID: 31036478
    [Abstract] [Full Text] [Related]

  • 17. An overview of familial Mediterranean fever with emphasis on pyrin and colchicine.
    Dbouk HA, Uthman IW.
    J Med Liban; 2008 Aug 16; 56(1):35-41. PubMed ID: 19534089
    [Abstract] [Full Text] [Related]

  • 18. Decreased vitamin D levels in children with familial Mediterranean fever.
    Anık A, Catlı G, Makay B, Abacı A, Küme T, Unsal E, Böber E.
    Int J Rheum Dis; 2014 Mar 16; 17(3):321-6. PubMed ID: 24410734
    [Abstract] [Full Text] [Related]

  • 19. Can colchicine response be predicted in familial Mediterranean fever patients?
    Özçakar ZB, Elhan AH, Yalçınkaya F.
    Rheumatology (Oxford); 2014 Oct 16; 53(10):1767-72. PubMed ID: 24764265
    [Abstract] [Full Text] [Related]

  • 20. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments.
    Ozen S, Kone-Paut I, Gül A.
    Semin Arthritis Rheum; 2017 Aug 16; 47(1):115-120. PubMed ID: 28413100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.